0102030405
Dabrafenib CAS No. 1195765-45-7 Pharmaceutical Intermediates
02
introduce
Dabrafenib is a cutting-edge targeted therapy used in the treatment of melanoma and other cancers that harbor the BRAF V600E mutation. As a potent BRAF inhibitor, it specifically targets and inhibits the mutated BRAF protein, which is responsible for uncontrolled cell growth in certain cancers. Our Dabrafenib is manufactured under stringent quality standards, ensuring consistent performance and reliability for pharmaceutical research and production.
02
Physical and chemical properties
- Molecular Formula: C23H20F3N5O2S2
- Molecular Weight: 519.56 g/mol
- Appearance: White to off-white crystalline powder
- Solubility: Soluble in polar organic solvents such as ethanol and DMSO; slightly soluble in water
- Melting Point: 200-205°C (decomposes)
- Stability: Stable under normal laboratory conditions but should be stored in a cool, dry place away from light and moisture
These properties make Dabrafenib a versatile and reliable choice for pharmaceutical manufacturers and researchers requiring high-purity active pharmaceutical ingredients (APIs).
- High Purity: Our product undergoes rigorous purification processes to achieve a purity level of ≥98%, ensuring accurate and reproducible results in your drug formulations.
- Targeted Action: Specifically inhibits the BRAF V600E mutation, offering a more precise and effective treatment option for certain cancers.
- Consistent Quality: Batch-to-batch consistency is guaranteed, making it a dependable choice for large-scale pharmaceutical production.
- Broad Compatibility: Compatible with a wide range of laboratory instruments and techniques, including HPLC, NMR, and mass spectrometry.
- Customizable Quantities: Available in various packaging sizes to meet the specific needs of small-scale laboratories and large-scale industrial applications.
Dabrafenib is widely used in:
- Cancer Treatment: As a targeted therapy for melanoma and other cancers with the BRAF V600E mutation, offering improved efficacy and reduced side effects compared to traditional chemotherapy.
- Pharmaceutical Research: Utilized in the development of novel cancer therapies and the optimization of existing drug formulations.
- Quality Control: Employed as a reference standard in analytical testing to ensure the quality and consistency of pharmaceutical products.
Our product is designed to meet the demands of modern pharmaceutical laboratories, ensuring seamless integration with high-performance systems. It is compatible with:
- High-Performance Liquid Chromatography (HPLC): For precise separation and analysis of chemical compounds.
- Nuclear Magnetic Resonance (NMR) Spectroscopy: For detailed structural characterization.
- Mass Spectrometry (MS): For accurate molecular weight determination and compound identification.
As a leading international trading company, we pride ourselves on delivering high-quality chemical products to customers worldwide. Our advantages include:
- Global Supply Chain: Efficient logistics and distribution networks ensure timely delivery to your location.
- Competitive Pricing: We offer cost-effective solutions without compromising on quality.
- Technical Support: Our team of experts is available to provide guidance and support for your pharmaceutical research and production needs.
- Commitment to Sustainability: We adhere to environmentally friendly practices in our manufacturing and distribution processes.
Dabrafenib is available in various quantities to suit your requirements. Contact us today to request a quote or to learn more about our product offerings.
Dabrafenib is a high-quality targeted therapy designed to meet the needs of advanced cancer treatment and pharmaceutical research. With its exceptional purity, stability, and targeted action, it is an indispensable tool for pharmaceutical manufacturers and researchers worldwide. Partner with us for reliable supply, competitive pricing, and unparalleled customer service. Let us help you achieve your pharmaceutical production and research goals with confidence.
Keywords for SEO: Dabrafenib, high-purity BRAF inhibitor, targeted cancer therapy, melanoma treatment, pharmaceutical research, laboratory instrument compatibility, global supplier, competitive pricing, technical support.